## **Core Concept**
Dubin-Johnson syndrome is a rare genetic disorder characterized by an inability to secrete conjugated bilirubin into the bile, leading to a chronic elevation of conjugated bilirubin levels in the blood. This condition is associated with mutations in the ABCC2 gene, which encodes for a canalicular multidrug resistance-associated protein 2 (MRP2) involved in bilirubin transport.

## **Why the Correct Answer is Right**
The correct answer, **D. Urinary coproporphyrin III**, is related to the diagnosis of Dubin-Johnson syndrome. In this condition, there is an increased excretion of urinary coproporphyrin III due to the impaired hepatic transport of organic anions, including coproporphyrin III. This test helps differentiate Dubin-Johnson syndrome from other causes of conjugated hyperbilirubinemia.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not directly relate to a commonly used test for diagnosing Dubin-Johnson syndrome.
- **Option B:** This option is incorrect as it is not specific to the diagnosis of Dubin-Johnson syndrome.
- **Option C:** This option is incorrect because, although liver function tests (LFTs) may show elevated levels of conjugated bilirubin, they are not specific for diagnosing Dubin-Johnson syndrome.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with Dubin-Johnson syndrome often have a bluish-black pigmentation (melanosis) in the liver due to the accumulation of melanin and epinephrine metabolites, which can be a clue to the diagnosis. Additionally, the condition is more common in males and may present with jaundice.

## **Correct Answer:** . Urinary coproporphyrin III